Sino-Biocan Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $14M

  • Investors
  • 5

Sino-Biocan General Information

Description

Developer of the solutions designed for cell preparation tools. The company focuses on immune scientific research, systemic solutions for immune cell therapy as well as supporting technology and consumable management, providing clients with high-quality laboratory products.

Contact Information

Formerly Known As
Sino Biocan (Beijing) Biotechnology, Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building 15, No. 6055, Jinhai Road
  • Fengxian District
  • Shanghai, 201403
  • China
+86 021
Primary Industry
Therapeutic Devices
Corporate Office
  • 2nd Floor, Building 15, No. 6055, Jinhai Road
  • Fengxian District
  • Shanghai, 201403
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sino-Biocan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 04-Mar-2024 $14M Completed Generating Revenue
4. Later Stage VC (Series A1) 15-Jul-2022 Completed Generating Revenue
3. Later Stage VC (Series A) 28-Feb-2022 Completed Generating Revenue
2. Later Stage VC 28-Aug-2021 Completed Generating Revenue
1. Early Stage VC 21-Mar-2017 Completed Generating Revenue
To view Sino-Biocan’s complete valuation and funding history, request access »

Sino-Biocan Patents

Sino-Biocan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025035894-A1 Cell fluid dispensing method Inactive 11-Aug-2023
WO-2024187983-A1 Centrifuge devices and separation methods using the centrifuge devices Inactive 13-Mar-2023
WO-2024187683-A1 Magnetic cell sorting Inactive 13-Mar-2023
EP-4547819-A1 Managing peripheral blood cells Pending 09-Aug-2022
EP-4547819-A4 Managing peripheral blood cells Pending 09-Aug-2022 A61M1/3695
To view Sino-Biocan’s complete patent history, request access »

Sino-Biocan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sino-Biocan Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dalton Venture Venture Capital Minority
Jinjue Investment Management Growth/Expansion Minority
Neovision Capital Venture Capital Minority
Grand Flight Corporate Venture Capital Minority
Sinovation Ventures Venture Capital Minority
To view Sino-Biocan’s complete investors history, request access »

Sino-Biocan FAQs

  • When was Sino-Biocan founded?

    Sino-Biocan was founded in 2013.

  • Where is Sino-Biocan headquartered?

    Sino-Biocan is headquartered in Shanghai, China.

  • What is the size of Sino-Biocan?

    Sino-Biocan has 19 total employees.

  • What industry is Sino-Biocan in?

    Sino-Biocan’s primary industry is Therapeutic Devices.

  • Is Sino-Biocan a private or public company?

    Sino-Biocan is a Private company.

  • What is Sino-Biocan’s current revenue?

    The current revenue for Sino-Biocan is .

  • How much funding has Sino-Biocan raised over time?

    Sino-Biocan has raised $21.8M.

  • Who are Sino-Biocan’s investors?

    Dalton Venture, Jinjue Investment Management, Neovision Capital, Grand Flight, and Sinovation Ventures have invested in Sino-Biocan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process